Clinical outcomes and hemodynamic performance of Dafodil™ aortic and mitral pericardial bioprosthesis: 1-year results from Dafodil-1 first-in-human trial

BACKGROUND: Bioprosthesis has been increasingly implanted for the treatment of transvalvular disease across the world. A new Dafodil™ pericardial bioprosthesis (Meril Life Sciences Pvt. Ltd., India) recently approved by Conformité Européenne (CE) is a tri-leaflet, stented, bovine valve. The purpose...

Descripción completa

Detalles Bibliográficos
Autores principales: Hiremath, C. S., Jain, Anil R., Garg, Anurag, Gupta, Nirmal, Mishra, Yugal K., Meharwal, Zile Singh, Thakur, Nityanand, Maslekar, Atul A., Shastri, Naman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294644/
https://www.ncbi.nlm.nih.gov/pubmed/32539847
http://dx.doi.org/10.1186/s13019-020-01154-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294644/
https://www.ncbi.nlm.nih.gov/pubmed/32539847
http://dx.doi.org/10.1186/s13019-020-01154-7

Ejemplares similares